InvestSMART

Patrys Limited (ASX: PAB) - Announcements

- Current share price for PAB : $0.023

ASX company news and announcements for Patrys Limited (PAB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Patrys Limited (PAB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Patrys Limited (PAB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Patrys Limited (PAB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$16 Change of Auditor 11 Nov 2026 6:36PM $0.023 $0.023 fallen by 0%
$16 Change in substantial holding 9 Nov 2026 6:08PM $0.020 $0.023 risen by 15%
$16 Change of Director's Interest Notice x2 9 Nov 2026 6:04PM $0.020 $0.023 risen by 15%
$16 Cleansing Notice 9 Nov 2026 6:00PM $0.020 $0.023 risen by 15%
$16 Application for quotation of securities - PAB 9 Nov 2026 5:58PM $0.020 $0.023 risen by 15%
$16 Letter to Shareholders - Annual General Meeting 30 Oct 2026 8:06AM $0.025 $0.023 fallen by 8%
$16 Notice of Annual General Meeting/Proxy Form 30 Oct 2026 8:06AM $0.025 $0.023 fallen by 8%
$16 Appendix 4C - Quarterly - 30 September 2026 29 Oct 2026 8:11AM $0.025 $0.023 fallen by 8%
$16 RLS-2202 Phase 1a Trial Advances to Cohort 2 22 Oct 2026 8:18AM $0.028 $0.023 fallen by 17.86%
$16 Investor Presentation 13 Oct 2026 8:12AM $0.030 $0.023 fallen by 23.33%
$16 Investor Webinar 6 Oct 2026 10:26AM $0.030 $0.023 fallen by 23.33%
$16 Date of AGM and Closing Date for Director Nominations 5 Oct 2026 7:34PM $0.030 $0.023 fallen by 23.33%
$16 Notification of cessation of securities - PAB 30 Sep 2026 4:53PM $0.031 $0.023 fallen by 25.81%
$16 Patrys Completes Cohort 1 Dosing and Follow-Up 29 Sep 2026 8:13AM $0.030 $0.023 fallen by 23.33%
$16 Appendix 4E Variance Report 28 Sep 2026 5:32PM $0.030 $0.023 fallen by 23.33%
$16 Annual Report - 30 June 2025 28 Sep 2026 5:32PM $0.030 $0.023 fallen by 23.33%
$16 Appendix 4G and Corporate Governance Statement 28 Sep 2026 5:26PM $0.030 $0.023 fallen by 23.33%
$16 First Participants Dosed in RLS-2202 Phase 1A Clinical Trial 23 Sep 2026 8:57AM $0.033 $0.023 fallen by 30.30%
$16 PAB Establishes Clinical Advisory Committee 17 Sep 2026 8:32AM $0.034 $0.023 fallen by 32.35%
$16 Appendix 4E - Preliminary Final Report 31 Aug 2026 7:03PM $0.030 $0.023 fallen by 23.33%
$16 Ethics Approval Secured for Phase 1A Clinical Trial 28 Aug 2026 8:12AM $0.030 $0.023 fallen by 23.33%
$16 Investor Presentation - TechKnow Invest Roadshow 27 Jul 2026 8:28AM $0.037 $0.023 fallen by 37.84%
$16 Appendix 4C - Quarterly - 30 June 2026 22 Jul 2026 9:35AM $0.036 $0.023 fallen by 36.11%
$16 Cleansing Notice 15 Jul 2026 6:13PM $0.038 $0.023 fallen by 39.47%
$16 Notification regarding unquoted securities - PAB 15 Jul 2026 6:12PM $0.038 $0.023 fallen by 39.47%

1 - 25 of 700 results

Page 1 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.